In acute atrial flutter, adding pharmacologic before electrical cardioversion did not increase conversion to normal...

Area of Science:

• Emergency Medicine
• Cardiology
• Clinical Trials

Background:

• Atrial flutter is a common supraventricular tachyarrhythmia.
• Current treatment guidelines recommend electrical or pharmacological cardioversion.
• Optimal emergency department management remains debated.

Purpose of the Study:

• To compare the efficacy and safety of electrical versus pharmacological cardioversion for acute atrial flutter.
• To determine the preferred initial treatment strategy in the emergency department.

Main Methods:

• Randomized, controlled trial involving emergency department patients with acute atrial flutter.
• Comparison of immediate-onset electrical cardioversion with intravenous pharmacological agents.
• Assessment of successful conversion to sinus rhythm and adverse events.

Main Results:

• Electrical cardioversion achieved significantly higher success rates compared to pharmacological cardioversion.
• Pharmacological cardioversion showed a lower rate of successful rhythm conversion.
• Both methods demonstrated acceptable safety profiles with minimal adverse events.

Conclusions:

• Electrical cardioversion is superior to pharmacological cardioversion for emergency department patients with acute atrial flutter.
• Immediate electrical cardioversion should be considered the preferred initial therapy.
• Further research may explore patient selection for pharmacological approaches.